
KRAS - Wikipedia
KRAS (Kirsten rat sarcoma virus) is a gene that provides instructions for making a protein called K-Ras, a part of the RAS/MAPK pathway. The protein relays signals from outside the cell to …
What’s new in KRAS mutation research? - MD Anderson Cancer …
Apr 4, 2024 · The most frequently mutated of these oncogenic driver genes, called KRAS, is associated with some of the most fatal cancer types: lung, pancreatic and colorectal cancers.
KRAS mutation: from undruggable to druggable in cancer
Nov 15, 2021 · As the most frequently mutated oncogene, Kirsten rat sarcoma viral oncogene homologue (KRAS) has attracted substantial attention. The understanding of KRAS is …
KRAS and Lung Cancer - American Lung Association
Jan 22, 2025 · What is a KRAS mutation? KRAS-positive lung cancer patient, Jennifer, shares what she would tell a newly diagnosed KRAS-lung cancer patient. Dr. Melissa Johnson …
The current understanding of KRAS protein structure and dynamics
GTPase KRas (KRAS) is a signal transducer protein, which plays an important role in various cellular signalling events such as in regulation of cell proliferation. It is a critical hub in the cell …
KRAS gene: MedlinePlus Genetics
The KRAS gene provides instructions for making a protein called K-Ras that is part of a signaling pathway known as the RAS/MAPK pathway. The protein relays signals from outside the cell to …
KRAS Mutations in Solid Tumors: Characteristics, Current …
Kristen rat sarcoma (KRAS) gene is one of the most common mutated oncogenes in solid tumors. Yet, KRAS inhibitors did not follow suit with the development of targeted therapy, for the …
Oncogenic KRAS: Signaling and Drug Resistance - PMC
KRAS is one of the oncogenic proteins and best well-known GTPase proteins. Although KRAS serves as regulation of cellular process, abnormal mutated and GTP-bound KRAS is highly …
Targeting KRAS in cancer - Nature Medicine
Apr 18, 2024 · Herein, we outline RAS pathobiology with a focus on KRAS, illustrate therapeutic approaches across a variety of malignancies, including emphasis on the ‘on’ and ‘off’ switch …
KRAS - Know Your Biomarker
All patients with stage IV / metastatic colorectal cancer should have KRAS biomarker testing. KRAS is a gene involved in controlling cell growth and cell survival. 40% of colorectal cancers …
- Some results have been removed